• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减重手术对心血管风险特征的影响。

Effect of bariatric surgery on cardiovascular risk profile.

机构信息

Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Am J Cardiol. 2011 Nov 15;108(10):1499-507. doi: 10.1016/j.amjcard.2011.06.076. Epub 2011 Aug 30.

DOI:10.1016/j.amjcard.2011.06.076
PMID:21880286
Abstract

Obesity is associated with increased risk for cardiovascular (CV) disease (CVD) and CV mortality. Bariatric surgery has been shown to resolve or improve CVD risk factors, to varying degrees. The objective of this systematic review was to determine the impact of bariatric surgery on CV risk factors and mortality. A systematic review of the published research was performed to evaluate evidence regarding CV outcomes in morbidly obese bariatric patients. Two major databases (PubMed and the Cochrane Library) were searched. The review included all original reports reporting outcomes after bariatric surgery, published in English, from January 1950 to July 2010. In total, 637 studies were identified from the initial screen. After applying inclusion and exclusion criteria, 52 studies involving 16,867 patients were included (mean age 42 years, 78% women). The baseline prevalence of hypertension, diabetes, and dyslipidemia was 49%, 28%, and 46%, respectively. Mean follow-up was 34 months (range 3 to 155), and the average excess weight loss was 52% (range 16% to 87%). Most studies reported significant decreases postoperatively in the prevalence of CV risk factors, including hypertension, diabetes, and dyslipidemia. Mean systolic pressure reduced from to 139 to 124 mm Hg and diastolic pressure from 87 to 77 mm Hg. C-reactive protein decreased, endothelial function improved, and a 40% relative risk reduction for 10-year coronary heart disease risk was observed, as determined by the Framingham risk score. In conclusion, this review highlights the benefits of bariatric surgery in reducing or eliminating risk factors for CVD. It provides further evidence to support surgical treatment of obesity to achieve CVD risk reduction.

摘要

肥胖与心血管疾病(CVD)和 CVD 死亡率的增加有关。减重手术已被证明可以在不同程度上解决或改善 CVD 的危险因素。本系统综述的目的是确定减重手术对心血管危险因素和死亡率的影响。对已发表的研究进行了系统的文献回顾,以评估肥胖症患者接受减重手术后心血管结局的证据。检索了两个主要数据库(PubMed 和 Cochrane Library)。该综述包括了自 1950 年 1 月至 2010 年 7 月期间发表的所有以英语报告减重手术后结果的原始报告。最初筛选出了 637 项研究。在应用纳入和排除标准后,纳入了 52 项涉及 16867 名患者的研究(平均年龄 42 岁,78%为女性)。基线高血压、糖尿病和血脂异常的患病率分别为 49%、28%和 46%。平均随访时间为 34 个月(范围 3 至 155 个月),平均超重减轻 52%(范围 16%至 87%)。大多数研究报告手术后心血管危险因素的患病率显著下降,包括高血压、糖尿病和血脂异常。收缩压从 139mmHg 降至 124mmHg,舒张压从 87mmHg 降至 77mmHg。C 反应蛋白降低,内皮功能改善,通过弗雷明汉风险评分,观察到 10 年冠心病风险降低 40%的相对风险。总之,本综述强调了减重手术在降低或消除 CVD 风险因素方面的益处。它提供了进一步的证据,支持手术治疗肥胖症以降低 CVD 风险。

相似文献

1
Effect of bariatric surgery on cardiovascular risk profile.减重手术对心血管风险特征的影响。
Am J Cardiol. 2011 Nov 15;108(10):1499-507. doi: 10.1016/j.amjcard.2011.06.076. Epub 2011 Aug 30.
2
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
3
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.肥胖症减肥干预措施以提高子宫内膜癌女性的生存率。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3.
4
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
5
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
6
Bariatric surgery and cardiovascular outcomes: a systematic review.减重手术与心血管结局:系统综述。
Heart. 2012 Dec;98(24):1763-77. doi: 10.1136/heartjnl-2012-301778. Epub 2012 Oct 17.
7
Blood pressure lowering efficacy of renin inhibitors for primary hypertension.肾素抑制剂对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2017 Apr 5;4(4):CD007066. doi: 10.1002/14651858.CD007066.pub3.
8
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
9
Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus.用于预防糖尿病患者心血管并发症的抗高血压治疗。
Cochrane Database Syst Rev. 2000;1997(2):CD002188. doi: 10.1002/14651858.CD002188.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
Guillain-Barré Syndrome and Related Neuropathies Post-Bariatric Surgery: A Systematic Review of Clinical Cases and Outcomes.减重手术后的吉兰-巴雷综合征及相关神经病变:临床病例与结局的系统评价
Obes Surg. 2025 Sep 2. doi: 10.1007/s11695-025-08192-x.
2
Metabolomic Alterations in Patients with Obesity and the Impact of Metabolic Bariatric Surgery: Insights for Future Research.肥胖患者的代谢组学改变及代谢性减肥手术的影响:对未来研究的启示
Metabolites. 2025 Jun 26;15(7):434. doi: 10.3390/metabo15070434.
3
Long-term changes in lipid indices following Roux-en-Y gastric bypass: a meta-analysis.
Roux-en-Y胃旁路术后脂质指标的长期变化:一项荟萃分析。
Surg Endosc. 2025 May 5. doi: 10.1007/s00464-025-11745-x.
4
Five-year outcomes of a randomized controlled trial evaluating a non-adjustable ring in Roux-en-Y gastric bypass.一项评估Roux-en-Y胃旁路术中不可调节环的随机对照试验的五年结果
Surg Endosc. 2025 Apr;39(4):2324-2334. doi: 10.1007/s00464-025-11545-3. Epub 2025 Feb 14.
5
Bariatric Surgery in Obesity: Metabolic Quality Analysis and Comparison of Surgical Options.肥胖症的减重手术:代谢质量分析及手术方案比较。
Adv Exp Med Biol. 2024;1460:697-726. doi: 10.1007/978-3-031-63657-8_24.
6
Exploring the links between types 2 diabetes and liver-related complications: A comprehensive review.探讨 2 型糖尿病与肝脏相关并发症之间的联系:全面综述。
United European Gastroenterol J. 2024 Mar;12(2):240-251. doi: 10.1002/ueg2.12508. Epub 2023 Dec 16.
7
Cardiovascular Effects of Weight Loss in Obese Patients with Diabetes: Is Bariatric Surgery the Additional Arrow in the Quiver?肥胖糖尿病患者体重减轻的心血管效应:减肥手术是箭袋中的又一支箭吗?
Life (Basel). 2023 Jul 13;13(7):1552. doi: 10.3390/life13071552.
8
Single injection of lidocaine to reduce tourniquet hypertension in ambulatory arthroscopic patients under general anaesthesia: randomized, double-blind, placebo-controlled clinical trial.单次注射利多卡因减少全身麻醉下门诊关节镜手术患者止血带高血压:随机、双盲、安慰剂对照临床试验。
BJS Open. 2023 Mar 7;7(2). doi: 10.1093/bjsopen/zrad014.
9
Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism.抗糖尿病治疗与心力衰竭:临床证据和分子机制的最新进展
Life (Basel). 2023 Apr 16;13(4):1024. doi: 10.3390/life13041024.
10
Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease.肥胖症合并非酒精性脂肪性肝病成人行减重手术与心血管结局的相关性。
JAMA Netw Open. 2022 Oct 3;5(10):e2235003. doi: 10.1001/jamanetworkopen.2022.35003.